Lidocain clinical trials
Lidocain is named as an intervention in 2 current clinical trials in our France register. 1 is recruiting patients now. All registered phases are Phase 3. The lead sponsor is Nantes University Hospital. The most-studied condition is Vaso-Occlusive Pain Episode in Sickle Cell Disease.
What health systems spend on Lidocain
All medicines →From NHSBSA Prescription Cost Analysis (Open Government Licence v3.0) and CMS State Drug Utilization Data. Both are gross amounts: neither system publishes its discounts or rebates per drug. Products combining several substances are not counted here.
How Lidocain works
All drug targets →- Sodium channel alpha subunit blocker BlockerTarget: Sodium channel alpha subunit✓ In ChEMBL and the Guide to Pharmacology
- Chronic painPhase 3
- CoughPhase 3
- Digital flexor tenosynovitisPhase 3
- DyspareuniaPhase 3
- DyspneaPhase 3
- Ehlers-Danlos syndrome, hypermobility typePhase 3
- HeadachePhase 3
- Hoarse voicePhase 3
- Hydrocele testisPhase 3
- LaryngospasmPhase 3
Mechanisms and diseases from ChEMBL via the Open Targets Platform (release 26.09), ChEMBL record CHEMBL79, CC BY-SA 3.0. Targets checked against the IUPHAR/BPS Guide to PHARMACOLOGY (2026.3), ligand 2623, CC BY-SA 4.0. Trial phases are not approvals: approved uses are shown from the regulators' own records where we hold them.
Patient leaflets for Lidocain
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- IEIreland: 16 products on the HPRA listEach product record links to the HPRA, which publishes the leaflet and SmPC.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Reference identifiers for Lidocain
- ChEMBL
- CHEMBL79
- DrugBank
- DB00281
- PubChem CID
- 3676
- CAS number
- 137-58-6
- FDA UNII
- 98PI200987
- Wikidata
- Q216935
- Wikipedia
- Lidocaine
Codes that identify this medicine in other databases, from Wikidata (CC0), matched by its ChEMBL ID. The ATC code is the WHO classification of what the medicine is used for.
Trials by status
Trials by phase
Clinical trials of Lidocain
2 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease
NCT07274254 · ClinicalTrials.gov ↗ · Vaso-Occlusive Pain Episode in Sickle Cell Disease
|
Phase 3 | Recruiting | Nantes University Hospital | France |
|
"Evaluation of the Efficacy of Intravenous Lidocaine on Chronic Post-operative Pain in Patients Requiring Emergency Abdominal Surgery. A Multicentre, Randomised, Controlled, Double-blind Study."
NCT07869173 · ClinicalTrials.gov ↗ · Chronic Pain
|
Phase 3 | Not yet open | Nantes University Hospital | France |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Conditions studied with Lidocain
2 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| Nantes University Hospital | 2 |
By country register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in France | 2 | 1 |
A trial with sites in more than one country appears in each of those registers.
Questions about Lidocain trials
How many clinical trials are testing Lidocain?
2 current trials in our France register name Lidocain as a drug or biological intervention, as of the registry sync on 11 October 2026. Completed and withdrawn studies are not counted.
Are Lidocain trials recruiting patients?
Yes. 1 of the 2 trials is recruiting: 1 with sites in France. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Lidocain clinical trials?
The lead sponsor is Nantes University Hospital. The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Lidocain works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Lidocain works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Lidocain (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 11 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.